1AIK | N:,C: | HIV GP41 CORE STRUCTURE |
1CZQ | A: | CRYSTAL STRUCTURE OF THE D10-P1/IQN17 COMPLEX: A D-PEPTIDE INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 COILED-COIL POCKET. |
1DF4 | A: | INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR IMPLICATIONS FOR MEMBRANE FUSION |
1DF5 | A: | INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR IMPLICATIONS FOR MEMBRANE FUSION |
1DLB | A: | HELICAL INTERACTIONS IN THE HIV-1 GP41 CORE REVEALS STRUCTURAL BASIS FOR THE INHIBITORY ACTIVITY OF GP41 PEPTIDES |
1ENV | A: | ATOMIC STRUCTURE OF THE ECTODOMAIN FROM HIV-1 GP41 |
1F23 | A:; B:; C:; D:; E:; F: | CONTRIBUTION OF A BURIED HYDROGEN BOND TO HIV-1 ENVELOPE GLYCOPROTEIN STRUCTURE AND FUNCTION |
1FAV | A:,C: | THE STRUCTURE OF AN HIV-1 SPECIFIC CELL ENTRY INHIBITOR IN COMPLEX WITH THE HIV-1 GP41 TRIMERIC CORE |
1GZL | A:,C:; B:,D: | CRYSTAL STRUCTURE OF C14LINKMID/IQN17: A CROSS-LINKED INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 HYDROPHOBIC POCKET |
1I5X | A: | HIV-1 GP41 CORE |
1I5Y | A: | HIV-1 GP41 CORE |
1K33 | A: | CRYSTAL STRUCTURE ANALYSIS OF THE GP41 CORE MUTANT |
1K34 | A: | CRYSTAL STRUCTURE ANALYSIS OF GP41 CORE MUTANT |
1QR8 | A: | INHIBITION OF HIV-1 INFECTIVITY BY THE GP41 CORE: ROLE OF A CONSERVED HYDROPHOBIC CAVITY IN MEMBRANE FUSION |
1QR9 | A: | INHIBITION OF HIV-1 INFECTIVITY BY THE GP41 CORE: ROLE OF A CONSERVED HYDROPHOBIC CAVITY IN MEMBRANE FUSION |
1SZT | A: | ATOMIC STRUCTURE OF A THERMOSTABLE SUBDOMAIN OF HIV-1 GP41 |
2OT5 | A: | CRYSTAL STRUCTURE OF THE HIV GP41 CORE WITH THE ENFUVIRTIDE RESISTANCE MUTATION N43D |
2Q3I | A:1-45 | CRYSTAL STRUCTURE OF THE D10-P3/IQN17 COMPLEX: A D-PEPTIDE INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 COILED-COIL POCKET |
2Q5U | A:1-45; B:1-45; C:1-45 | CRYSTAL STRUCTURE OF IQN17 |
2Q7C | A:1-45; B:1-45; C:1-45 | CRYSTAL STRUCTURE OF IQN17 |
3CP1 | A: | STRUCTURE OF A LONGER THERMALSTABLE CORE DOMAIN OF HIV-1 GP41 CONTAINING THE ENFUVIRTIDE RESISTANCE MUTATION N43D |
3CYO | A: | STRUCTURE OF A LONGER THERMALSTABLE CORE DOMAIN OF HIV-1 GP41 CONTAINING THE ENFUVIRTIDE RESISTANCE MUTATION N43D AND COMPLEMENTARY MUTATION E137K |
3WFV | A: | HIV-1 CRF07 GP41 |